MK-8777

unknown · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8777, covering 2014-08-29 to 2014-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) [Phase 2]

See pricing